Our original name.
Aforé begins developing and selling skincare. The first collection establishes the company’s foundation in daily skincare, with the Aforé name on the bottle from the beginning.
Our story
The original name. A new chapter shaped by research.
Our story began as Aforé in 2019. Through the Dr. Few Skincare years, the collection grew and the research deepened. Behind that work was Alec Semersky, our co-founder and formulator, connecting the details of product development with published clinical research.
In 2026, we return to Aforé with a sharper focus: skincare for the visible changes that can accompany aesthetic and weight-change journeys. DermaReverse brings that focus into view, building on years of formulation experience and a published, placebo-controlled study.
Aforé LLC has always been independently owned. The name on the bottle has evolved; our company’s story continues.
7
Medical journal publications since 2016
Alec Semersky
CEO, Co-Founder & Formulator
A history of recognition
Award-winning roots.
Aforé has a history of award-winning skincare formulations, recognized by some of the most respected names in beauty, fashion, and luxury media.
The path here
One company.
Three chapters.
Returning to Aforé means bringing our original identity and the work that followed into the same story. The early collection established our roots. The Dr. Few Skincare years expanded the portfolio and its published research. DermaReverse now gives that experience a focused next chapter.
The portfolio grows.
The collection is presented as Dr. Few Skincare while Aforé LLC remains the company behind it. Alec’s published skincare work spans retinol, a multi-product routine and, in 2025, the placebo-controlled study behind DermaReverse.
Back to Aforé.
Built on what came before.
Our original name returns to the forefront, with DermaReverse leading a clearer focus on visible skin quality through change. The next chapter carries our formulation experience and published research forward.
Independently owned, from the beginning. Aforé LLC has never been private-equity owned. The brand’s evolution is a continuation of the same company, not the start of a new one.
The product mind
Chemistry nerd at heart.
Formulator by practice.
Alec Semersky is CEO, Co-Founder and Formulator of Aforé. His published bylines trace a progression from manager to product developer to chief operating officer before he became CEO in 2026.
He is first and corresponding author of the blinded, placebo-controlled clinical study behind DermaReverse, and co-author of six further medical journal publications across skincare and aesthetic medicine since 2016.
First + corresponding author
Lead author of the 2025 single-center, blinded, placebo-controlled, split-face study behind DermaReverse.
View the publication ↗Medical journal publications
Six research articles and one invited commentary, with published work dating to 2016.
Formulations
Inventor and formulator of 11 state-of-the-art clinically-tested skincare formulas.
Clinical studies & journal publications
Explore Alec’s published work across skincare and aesthetic medicine, dating to 2016. Each entry identifies the research topic and his authorship role. All publication links open in a new tab.
Skincare formulation & routine studies
-
2025
DermaReverse · GLPSGLT formulation
Peer-reviewed · Medical journal published
First and corresponding author. A six-week, single-center, blinded, placebo-controlled, split-face study evaluating the study serum in people using GLP-1 receptor agonist or SGLT-2 therapy.
Evaluates the finished study formulation. Individual results may vary.
Semersky et al. · Aesthetic Surgery Journal Open Forum, 2025 · DOI: 10.1093/asjof/ojaf030
Read the published study -
2024
The four-product skincare routine
Second and corresponding author. A long-term retrospective study assessing a routine of Gentle Exfoliating Cleanser, Moisture Complete, Tinted Mineral Sunscreen SPF 30 and a retinol/peptide topical.
The paper describes a glycolic acid cleanser, combination moisturizer, 25% zinc oxide sunscreen and retinol/peptide topical. These were studied together, not in four separate trials. Individual product effects were not isolated, concurrent cosmetic procedures limit attribution, and this is not an SPF performance test.
Pryor et al. · Aesthetic Surgery Journal Open Forum, 2024 · DOI: 10.1093/asjof/ojae037
Read the published study -
2022
The retinol + CBD development study
Co-author. A 42-day, single-center prospective study evaluating a topical combination of retinol and cannabidiol, without a placebo comparison.
Part of Alec’s formulation-development research record. The studied topical contained CBD and differs from the CBD-free Clean Retinol product, so this paper is not presented as evidence for that later formula.
Few et al. · Aesthetic Surgery Journal Open Forum, 2022 · DOI: 10.1093/asjof/ojac002
Read the published study
Additional research collaboration
-
2023
Goop Beauty Youth-Boost Peptide Serum
Co-author. A single-center study evaluating a serum combining postbiotics, peptides and botanical extracts, assessed over 42 days.
Included as a research collaboration, not an Aforé product or a formulation credit. Facial outcomes were compared with baseline; a placebo comparison was limited to an exploratory forearm assessment. No current partnership is implied.
Few et al. · Aesthetic Surgery Journal Open Forum, 2023 · DOI: 10.1093/asjof/ojad055
Read the published study
Aesthetic medicine research
-
2018
Facial rejuvenation with absorbable sutures
Co-author. An analysis of 100 patients undergoing absorbable suture suspension, published as “Rejuvenating the Face: An Analysis of 100 Absorbable Suture Suspension Patients.”
Research into an aesthetic procedure; this publication does not evaluate a topical skincare formula.
Ogilvie et al. · Aesthetic Surgery Journal, 2018 (published online 2017) · DOI: 10.1093/asj/sjx202
Read the published study -
2018
Brow rejuvenation & transpalpebral browpexy
Co-author. “What Neurotoxins Have Taught Us About the Brow: The Reintroduction and Review of the Transpalpebral Browpexy,” examining an approach to brow rejuvenation.
Research into brow positioning and an aesthetic procedure, separate from Alec’s skincare studies.
Ogilvie et al. · Aesthetic Plastic Surgery, 2018 (published online 2017) · DOI: 10.1007/s00266-017-0988-7
Read the published study
Invited commentary
-
2016
Microneedling depth & clinical applications
Second author. An invited commentary on microneedling depth, pigment particles and fluorescein-stained platelets in aesthetic applications, co-authored with Julius W. Few.
Published commentary on another research paper; it is not an original clinical trial or a skincare formulation study.
Few and Semersky · Aesthetic Surgery Journal · Published online 2016; print 2017 · DOI: 10.1093/asj/sjw133
Read the published commentary
Building the company around the work
Brandon Parrish
Partner, Chief of Strategy
Brandon brings more than two decades of insurance experience and a business owner’s perspective to Aforé’s strategy, partnerships, and growth.
Licensed in insurance since 2003, his background spans commercial insurance, employee benefits, international medical coverage, and business risk management. His career combines advising business owners with firsthand experience building businesses, developing partnerships, and managing the operational decisions that shape long-term success. His work in health insurance and employee benefits provides a practical understanding of how coverage, cost, and access influence healthcare decisions. At Aforé, that perspective informs his work developing pharmacy and telehealth relationships serving people on GLP-1 and weight-management journeys. Working alongside Alec Semersky, Brandon helps guide business strategy, operations, vendor relationships, and the systems that support Aforé’s growth, translating the brand’s product and research foundation into a sustainable business.
View LinkedIn ↗The team
The people bringing Aforé forward.
Research and formulation are only part of the work. Aforé’s team carries that foundation into retail, education, community and content.
Karen Broderick
Retail Sales, Event & Education Director
Karen brings senior beauty-industry experience across retail sales, education, brand building and team leadership. She connects Aforé with retail partners and brings the brand’s product and clinical story to life through education and events.
View LinkedIn ↗
Isabella Stolberg
Community & Social Media Manager
With a background in fashion merchandising and communication technologies, Isabella leads day-to-day social publishing, community engagement, creator partnerships, campaign coordination and performance reporting.
View LinkedIn ↗
Ryne Iseminger
Director of Social Media & Content
A consumer-brand founder with hands-on marketing experience, Ryne brings more than a decade of work across social strategy, photography, content and storytelling. He leads Aforé’s social media and content direction with an operator’s understanding of how brands are built and grown.
View LinkedIn ↗The work continues
Our original name.
Our next chapter.
The curiosity, formulation experience and published research behind Aforé come together in a simple commitment: thoughtful skincare for skin moving through change.